 Reed Ayers
Concepts (129)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Spine | 2 | 2017 | 182 | 0.920 |
Why?
| | Bone Substitutes | 3 | 2017 | 26 | 0.810 |
Why?
| | Prostheses and Implants | 3 | 2017 | 142 | 0.740 |
Why?
| | Hardness | 2 | 2017 | 17 | 0.560 |
Why?
| | Metals | 2 | 2017 | 140 | 0.500 |
Why?
| | Reoperation | 1 | 2017 | 631 | 0.410 |
Why?
| | Titanium | 4 | 2017 | 76 | 0.370 |
Why?
| | Materials Testing | 4 | 2017 | 348 | 0.340 |
Why?
| | Biocompatible Materials | 2 | 2007 | 436 | 0.300 |
Why?
| | Alloys | 3 | 2017 | 38 | 0.290 |
Why?
| | Durapatite | 2 | 1999 | 37 | 0.290 |
Why?
| | Osseointegration | 2 | 1999 | 59 | 0.290 |
Why?
| | Postoperative Complications | 1 | 2017 | 2962 | 0.210 |
Why?
| | Temperature | 1 | 2007 | 681 | 0.200 |
Why?
| | Bone Development | 2 | 2003 | 52 | 0.190 |
Why?
| | Bone and Bones | 3 | 2002 | 318 | 0.160 |
Why?
| | Maxilla | 1 | 1998 | 36 | 0.140 |
Why?
| | Corrosion | 1 | 2017 | 16 | 0.130 |
Why?
| | Porosity | 3 | 2007 | 95 | 0.130 |
Why?
| | Chromium | 1 | 2017 | 17 | 0.130 |
Why?
| | Skull | 1 | 1999 | 161 | 0.130 |
Why?
| | Ions | 1 | 2017 | 68 | 0.130 |
Why?
| | Cobalt | 1 | 2017 | 52 | 0.130 |
Why?
| | Stainless Steel | 1 | 2017 | 21 | 0.130 |
Why?
| | Pliability | 1 | 2017 | 48 | 0.130 |
Why?
| | Nickel | 1 | 2017 | 62 | 0.130 |
Why?
| | Phosphorus | 1 | 2017 | 98 | 0.130 |
Why?
| | Body Fluids | 1 | 2017 | 71 | 0.130 |
Why?
| | Equipment Failure Analysis | 1 | 2017 | 124 | 0.130 |
Why?
| | Elastic Modulus | 1 | 2017 | 121 | 0.130 |
Why?
| | Prosthesis Failure | 1 | 2017 | 125 | 0.120 |
Why?
| | Spinal Injuries | 1 | 2017 | 60 | 0.120 |
Why?
| | Iron | 2 | 2017 | 359 | 0.120 |
Why?
| | Reference Values | 1 | 2017 | 797 | 0.120 |
Why?
| | Lumbar Vertebrae | 1 | 2017 | 252 | 0.110 |
Why?
| | Skin Diseases | 2 | 2006 | 152 | 0.110 |
Why?
| | Patient-Centered Care | 1 | 2017 | 551 | 0.090 |
Why?
| | Patient Readmission | 1 | 2017 | 769 | 0.090 |
Why?
| | Biomechanical Phenomena | 4 | 2007 | 860 | 0.090 |
Why?
| | Calcium | 1 | 2017 | 1190 | 0.090 |
Why?
| | Bone Nails | 1 | 2011 | 61 | 0.080 |
Why?
| | Maxillofacial Prosthesis Implantation | 2 | 1999 | 2 | 0.080 |
Why?
| | Fibrosis | 2 | 2007 | 551 | 0.060 |
Why?
| | Calcium Phosphates | 1 | 2007 | 28 | 0.060 |
Why?
| | Gravitation | 1 | 2007 | 22 | 0.060 |
Why?
| | Tomography, X-Ray Computed | 1 | 2017 | 2772 | 0.060 |
Why?
| | Gases | 1 | 2007 | 53 | 0.060 |
Why?
| | Body Piercing | 1 | 2006 | 3 | 0.060 |
Why?
| | Gadolinium DTPA | 1 | 2007 | 70 | 0.060 |
Why?
| | Contrast Media | 2 | 2007 | 500 | 0.060 |
Why?
| | Gadolinium | 1 | 2006 | 84 | 0.060 |
Why?
| | Rabbits | 2 | 1999 | 651 | 0.060 |
Why?
| | Granuloma | 1 | 2006 | 97 | 0.060 |
Why?
| | Tibia | 2 | 1998 | 176 | 0.060 |
Why?
| | Dermatitis, Allergic Contact | 1 | 2006 | 73 | 0.060 |
Why?
| | Skin | 2 | 2007 | 766 | 0.050 |
Why?
| | Bone Diseases, Metabolic | 2 | 2003 | 58 | 0.050 |
Why?
| | Treatment Outcome | 1 | 2017 | 11831 | 0.050 |
Why?
| | Bone Resorption | 2 | 2002 | 81 | 0.040 |
Why?
| | Sialoglycoproteins | 1 | 2002 | 157 | 0.040 |
Why?
| | Kidney Failure, Chronic | 1 | 2007 | 600 | 0.040 |
Why?
| | Osteoporosis | 1 | 2003 | 237 | 0.040 |
Why?
| | Humans | 8 | 2017 | 145491 | 0.040 |
Why?
| | Hindlimb Suspension | 1 | 2000 | 11 | 0.040 |
Why?
| | Aging | 2 | 2003 | 1940 | 0.040 |
Why?
| | Haversian System | 1 | 1998 | 2 | 0.040 |
Why?
| | Cnidaria | 1 | 1998 | 6 | 0.040 |
Why?
| | Femur | 2 | 2003 | 254 | 0.040 |
Why?
| | Aged | 2 | 2017 | 26125 | 0.040 |
Why?
| | Maxillary Sinus | 1 | 1998 | 11 | 0.040 |
Why?
| | Middle Aged | 2 | 2017 | 36176 | 0.040 |
Why?
| | Humerus | 1 | 1998 | 40 | 0.040 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 1 | 2000 | 207 | 0.030 |
Why?
| | Bone Remodeling | 1 | 1998 | 71 | 0.030 |
Why?
| | Space Flight | 1 | 1998 | 71 | 0.030 |
Why?
| | Glycoproteins | 1 | 2000 | 353 | 0.030 |
Why?
| | Multiple Myeloma | 1 | 2002 | 309 | 0.030 |
Why?
| | Surface Properties | 1 | 1999 | 398 | 0.030 |
Why?
| | Osteoblasts | 1 | 1998 | 146 | 0.030 |
Why?
| | Animals | 8 | 2003 | 38141 | 0.030 |
Why?
| | Osteogenesis | 1 | 1998 | 207 | 0.030 |
Why?
| | Insulin-Like Growth Factor I | 1 | 1998 | 317 | 0.030 |
Why?
| | Analysis of Variance | 1 | 1998 | 1304 | 0.030 |
Why?
| | Energy Intake | 1 | 1999 | 506 | 0.030 |
Why?
| | Male | 6 | 2017 | 72817 | 0.030 |
Why?
| | Cats | 1 | 1996 | 228 | 0.030 |
Why?
| | Mice, Inbred C57BL | 4 | 2003 | 5989 | 0.030 |
Why?
| | Elasticity | 1 | 1996 | 191 | 0.030 |
Why?
| | Species Specificity | 1 | 1996 | 573 | 0.030 |
Why?
| | Rats | 3 | 2000 | 5581 | 0.030 |
Why?
| | Rats, Sprague-Dawley | 2 | 1998 | 2526 | 0.030 |
Why?
| | Stress, Mechanical | 1 | 1996 | 495 | 0.020 |
Why?
| | Female | 4 | 2017 | 78763 | 0.020 |
Why?
| | Bone Density | 3 | 2002 | 484 | 0.020 |
Why?
| | Mice | 5 | 2003 | 18338 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 1998 | 5426 | 0.020 |
Why?
| | Time Factors | 1 | 1999 | 7171 | 0.020 |
Why?
| | Electron Probe Microanalysis | 1 | 2006 | 3 | 0.020 |
Why?
| | Body Weight | 2 | 2003 | 970 | 0.020 |
Why?
| | Sampling Studies | 1 | 2007 | 98 | 0.020 |
Why?
| | Paraffin Embedding | 1 | 2006 | 31 | 0.020 |
Why?
| | Biopsy, Needle | 1 | 2007 | 185 | 0.020 |
Why?
| | Microscopy, Electron, Scanning | 1 | 2006 | 200 | 0.020 |
Why?
| | Lysosomes | 1 | 2006 | 128 | 0.010 |
Why?
| | Organ Specificity | 1 | 2006 | 312 | 0.010 |
Why?
| | Single-Blind Method | 1 | 2006 | 319 | 0.010 |
Why?
| | Acidosis | 1 | 2006 | 105 | 0.010 |
Why?
| | Renal Insufficiency | 1 | 2006 | 172 | 0.010 |
Why?
| | Diaphyses | 1 | 2003 | 10 | 0.010 |
Why?
| | Mass Spectrometry | 1 | 2007 | 744 | 0.010 |
Why?
| | Calcification, Physiologic | 1 | 2003 | 29 | 0.010 |
Why?
| | Immunohistochemistry | 1 | 2007 | 1710 | 0.010 |
Why?
| | Sensitivity and Specificity | 1 | 2007 | 2002 | 0.010 |
Why?
| | Pilot Projects | 1 | 2006 | 1896 | 0.010 |
Why?
| | Interleukin 1 Receptor Antagonist Protein | 1 | 2002 | 253 | 0.010 |
Why?
| | Osteoprotegerin | 1 | 2000 | 22 | 0.010 |
Why?
| | Placebos | 1 | 2000 | 193 | 0.010 |
Why?
| | Adolescent | 1 | 1999 | 22485 | 0.010 |
Why?
| | Receptors, Tumor Necrosis Factor | 1 | 2000 | 161 | 0.010 |
Why?
| | Hyaluronic Acid | 1 | 2002 | 225 | 0.010 |
Why?
| | Mice, Inbred BALB C | 1 | 2002 | 1261 | 0.010 |
Why?
| | Specific Pathogen-Free Organisms | 1 | 1998 | 58 | 0.010 |
Why?
| | Kidney | 1 | 2007 | 1498 | 0.010 |
Why?
| | Weightlessness | 1 | 1998 | 40 | 0.010 |
Why?
| | Interleukin-1 | 1 | 2002 | 961 | 0.010 |
Why?
| | Weight-Bearing | 1 | 1998 | 183 | 0.010 |
Why?
| | Interleukin-6 | 1 | 2002 | 772 | 0.010 |
Why?
| | Risk Assessment | 1 | 2007 | 3759 | 0.010 |
Why?
| | Adult | 1 | 1999 | 40707 | 0.010 |
Why?
|
|
Ayers's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|